News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,219 Results
Type
Article (44608)
Company Profile (474)
Press Release (697125)
Multimedia
Podcasts (130)
Webinars (20)
Section
Business (209684)
Career Advice (2043)
Deals (36245)
Drug Delivery (125)
Drug Development (84801)
Employer Resources (174)
FDA (16837)
Job Trends (15218)
News (355549)
Policy (33416)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2680)
Accelerated approval (39)
Adcomms (33)
Allergies (154)
Alliances (51280)
ALS (185)
Alzheimer's disease (1748)
Antibody-drug conjugate (ADC) (351)
Approvals (17078)
Artificial intelligence (573)
Autoimmune disease (173)
Automation (44)
Bankruptcy (374)
Best Places to Work (11856)
BIOSECURE Act (21)
Biosimilars (200)
Biotechnology (331)
Bladder cancer (170)
Brain cancer (63)
Breast cancer (677)
Cancer (5142)
Cardiovascular disease (445)
Career advice (1729)
Career pathing (39)
CAR-T (299)
CDC (50)
Celiac Disease (2)
Cell therapy (801)
Cervical cancer (38)
Clinical research (72305)
Collaboration (1868)
Company closure (4)
Compensation (1216)
Complete response letters (70)
COVID-19 (2784)
CRISPR (104)
C-suite (925)
Cystic fibrosis (152)
Data (6527)
Decentralized trials (2)
Denatured (41)
Depression (148)
Diabetes (520)
Diagnostics (6815)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (280)
Drug pricing (201)
Drug shortages (29)
Duchenne muscular dystrophy (254)
Earnings (91800)
Editorial (63)
Employer branding (21)
Employer resources (153)
Events (121787)
Executive appointments (1026)
FDA (20085)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1576)
Gene editing (223)
Generative AI (46)
Gene therapy (667)
GLP-1 (1037)
Government (4794)
Grass and pollen (6)
Guidances (386)
Healthcare (19248)
HIV (70)
Huntington's disease (49)
IgA nephropathy (89)
Immunology and inflammation (287)
Immuno-oncology (72)
Indications (128)
Infectious disease (3075)
Inflammatory bowel disease (209)
Inflation Reduction Act (17)
Influenza (125)
Intellectual property (264)
Interviews (316)
IPO (16974)
IRA (53)
Job creations (3722)
Job search strategy (1441)
JPM (67)
Kidney cancer (19)
Labor market (87)
Layoffs (590)
Leadership (35)
Legal (8044)
Liver cancer (96)
Longevity (17)
Lung cancer (695)
Lymphoma (389)
Machine learning (45)
Management (59)
Manufacturing (844)
MASH (173)
Medical device (13948)
Medtech (14008)
Mergers & acquisitions (20367)
Metabolic disorders (1356)
mRNA (186)
Multiple sclerosis (174)
NASH (19)
Neurodegenerative disease (357)
Neuropsychiatric disorders (100)
Neuroscience (3096)
Neurotech (1)
NextGen: Class of 2026 (6776)
Non-profit (4592)
Now hiring (69)
Obesity (651)
Opinion (294)
Ovarian cancer (171)
Pain (215)
Pancreatic cancer (245)
Parkinson's disease (308)
Partnered (34)
Patents (523)
Patient recruitment (536)
Peanut (61)
People (60477)
Pharmaceutical (86)
Pharmacy benefit managers (31)
Phase 1 (22714)
Phase 2 (31842)
Phase 3 (23592)
Pipeline (5834)
Policy (311)
Postmarket research (2633)
Preclinical (9695)
Press Release (67)
Prostate cancer (266)
Psychedelics (56)
Radiopharmaceuticals (309)
Rare diseases (948)
Real estate (6071)
Recruiting (71)
Regulatory (25269)
Reports (53)
Research institute (2504)
Resumes & cover letters (355)
Rett syndrome (28)
RNA editing (21)
RSV (81)
Schizophrenia (159)
Series A (267)
Series B (204)
Service/supplier (11)
Sickle cell disease (109)
Special edition (27)
Spinal muscular atrophy (165)
Sponsored (43)
Startups (3814)
State (2)
Stomach cancer (21)
Supply chain (108)
Tariffs (85)
The Weekly (87)
Vaccines (1051)
Venture capital (96)
Weight loss (425)
Women's health (100)
Worklife (20)
Date
Today (258)
Last 7 days (852)
Last 30 days (2936)
Last 365 days (30974)
2026 (4932)
2025 (31173)
2024 (36415)
2023 (41130)
2022 (52434)
2021 (56877)
2020 (55018)
2019 (47517)
2018 (35797)
2017 (33188)
2016 (32486)
2015 (38532)
2014 (32328)
2013 (27245)
2012 (29335)
2011 (29974)
2010 (28150)
Location
Africa (755)
Alabama (92)
Alaska (7)
Arizona (325)
Arkansas (15)
Asia (41049)
Australia (6819)
California (11837)
Canada (3375)
China (1173)
Colorado (497)
Connecticut (513)
Delaware (344)
Europe (90241)
Florida (1776)
Georgia (373)
Hawaii (3)
Idaho (61)
Illinois (912)
India (71)
Indiana (540)
Iowa (24)
Japan (452)
Kansas (131)
Kentucky (43)
Louisiana (28)
Maine (72)
Maryland (1438)
Massachusetts (8583)
Michigan (337)
Minnesota (648)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (29)
Nevada (125)
New Hampshire (85)
New Jersey (3146)
New Mexico (31)
New York (3092)
North Carolina (1569)
North Dakota (9)
Northern California (5792)
Ohio (351)
Oklahoma (21)
Oregon (45)
Pennsylvania (2381)
Puerto Rico (24)
Rhode Island (50)
South America (1125)
South Carolina (68)
South Dakota (1)
Southern California (4592)
Tennessee (180)
Texas (1814)
United States (42056)
Utah (357)
Vermont (1)
Virginia (278)
Washington D.C. (82)
Washington State (973)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
742,219 Results for "inhibitor therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aprea Therapeutics Announces Additional Positive Clinical Activity for WEE1 Inhibitor, APR-1051, Including Second Partial Response in Ongoing ACESOT-1051 Trial
February 18, 2026
·
7 min read
Press Releases
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
February 2, 2026
·
7 min read
Press Releases
HotSpot Therapeutics to Present Preclinical Data from Small Molecule IRF5 Inhibitor Program at 15th European Lupus Meeting
February 26, 2026
·
1 min read
Press Releases
Cadrenal Therapeutics Highlights High Incidence of Thrombotic Complications in Heparin-Induced Thrombocytopenia (HIT) at the J.P. Morgan Healthcare Conference and VLX-1005 as a Potential Therapeutic Solution as the First and Only Selective 12-LOX Inhibitor
January 12, 2026
·
7 min read
Press Releases
Rakovina Therapeutics Reports Strong Industry Validation and Emerging Collaborations Following 9th Annual DDR Inhibitors Summit
February 4, 2026
·
5 min read
Press Releases
Rakovina Therapeutics and Variational AI Expand Collaboration to Advance Next-Generation ATR Inhibitors
January 8, 2026
·
5 min read
Press Releases
Aprea Therapeutics Announces Early Clinical Proof-Of-Concept in the Ongoing ACESOT-1051 Dose-Escalation Trial Evaluating WEE1 Inhibitor APR-1051, Including Partial Response Observed on First Scan
January 29, 2026
·
7 min read
Press Releases
Nimbus Therapeutics to Present Preclinical and Translational Data on Novel SIK2 Inhibitors at 21st Congress of European Crohn’s and Colitis Organisation (ECCO)
February 17, 2026
·
3 min read
Press Releases
ImmuneSensor Therapeutics Doses First Patient with Aicardi Goutières Syndrome (AGS) in Phase 1b Clinical Study of cGAS inhibitor, IMSB301
February 12, 2026
·
5 min read
Multiple sclerosis
Beyond BTK Inhibitors: Next Gen MS Treatments Could Transcend Symptom Management
While Bruton’s tyrosine kinase inhibitors are often hailed as the next big breakthrough in multiple sclerosis, Immunic Therapeutics and others are leveraging neuroprotective targets and remyelination to keep the disease at bay.
October 6, 2025
·
5 min read
·
Ben Hargreaves
1 of 74,222
Next
